Overview of the coagulation system

Sanjeev Palta, Richa Saroa, Anshu Palta, Sanjeev Palta, Richa Saroa, Anshu Palta

Abstract

Coagulation is a dynamic process and the understanding of the blood coagulation system has evolved over the recent years in anaesthetic practice. Although the traditional classification of the coagulation system into extrinsic and intrinsic pathway is still valid, the newer insights into coagulation provide more authentic description of the same. Normal coagulation pathway represents a balance between the pro coagulant pathway that is responsible for clot formation and the mechanisms that inhibit the same beyond the injury site. Imbalance of the coagulation system may occur in the perioperative period or during critical illness, which may be secondary to numerous factors leading to a tendency of either thrombosis or bleeding. A systematic search of literature on PubMed with MeSH terms 'coagulation system, haemostasis and anaesthesia revealed twenty eight related clinical trials and review articles in last 10 years. Since the balance of the coagulation system may tilt towards bleeding and thrombosis in many situations, it is mandatory for the clinicians to understand physiologic basis of haemostasis in order to diagnose and manage the abnormalities of the coagulation process and to interpret the diagnostic tests done for the same.

Keywords: Anaesthesia; Coagulation system; haemostasis.

Conflict of interest statement

Conflict of Interest: None declared

Figures

Figure 1
Figure 1
Earlier concept of coagulation
Figure 2
Figure 2
Current concept of coagulation (initiation phase)
Figure 3
Figure 3
Current concepts of coagulation (propagation phase)
Figure 4
Figure 4
Regulation of the fibrinolytic system

References

    1. Achneck HE, Sileshi B, Parikh A, Milano CA, Welsby IJ, Lawson JH. Pathophysiology of bleeding and clotting in the cardiac surgery patient: from vascular endothelium to circulatory assist device surface. Circulation. 2010;122:2068–77.
    1. Thornton P, Douglas J. Coagulation in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2010;24:339–52.
    1. Previtali E, Bucciarelli P, Passamonti SM, Martinelli I. Risk factors for venous and arterial thrombosis. Blood Transfus. 2011;9:120–38.
    1. Bombeli T, Spahn DR. Updates in perioperative coagulation: Physiology and management of thromboembolism and haemorrhage. Br J Anaesth. 2004;93:275–87.
    1. Meybohm P, Zacharowski K, Weber CF. Point-of-care coagulation management in intensive care medicine. Crit Care. 2013;17:218.
    1. Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood. 1998;91:3527–61.
    1. Lasne D, Jude B, Susen S. From normal to pathological hemostasis. Can J Anesth. 2006;53:S2–11.
    1. Triplett DA. Coagulation and bleeding disorders: Review and update. Clin Chem. 2000;46:1260–9.
    1. Heemskerk JW, Bevers EM, Lindhout T. Platelet activation and blood coagulation. Thromb Haemost. 2002;88:186–93.
    1. Andrews RK, Berndt MC. Platelet physiology and thrombosis. Thromb Res. 2004;114:447–53.
    1. Ashby B, Daniel JL, Smith JB. Mechanisms of platelet activation and inhibition. Hematol Oncol Clin North Am. 1990;4:1–26.
    1. Yenicesu I, Yetgin S, Ozyürek E, Aslan D. Virus-associated immune thrombocytopenic purpura in childhood. Pediatr Hematol Oncol. 2002;19:433–7.
    1. Colvin BT. Physiology of haemostasis. Vox Sang. 2004;87(Suppl 1):43–6.
    1. Monroe DM, 3rd, Hoffman M, Roberts HR. Williams Hematology. 8th ed. New York NY: McGraw-Hill Professional Publishing; 2010. Molecular biology and biochemistry of the coagulation factors and pathways of hemostasis; pp. 614–6.
    1. Hall JE. Guyton and Hall Textbook of Medical Physiology: Enhanced E-Book. 11th ed. Philadelphia: Elsevier Health Sciences; 2010. Hemostasis and blood coagulation; pp. 457–9.
    1. Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem. 1998;67:395–424.
    1. Barash PG, Cullen BF, Stoelting RK, editors. 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2006. Clinical Anesthesia; pp. 224–6.
    1. Doolittle RF, Spraggon G, Everse SJ. Three-dimensional structural studies on fragments of fibrinogen and fibrin. Curr Opin Struct Biol. 1998;8:792–8.
    1. Kamath S, Lip GY. Fibrinogen: Biochemistry, epidemiology and determinants. QJM. 2003;96:711–29.
    1. Mackman N, Tilley RE, Key NS. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol. 2007;27:1687–93.
    1. Manly DA, Boles J, Mackman N. Role of tissue factor in venous thrombosis. Annu Rev Physiol. 2011;73:515–25.
    1. Myers DD, Hawley AE, Farris DM, Wrobleski SK, Thanaporn P, Schaub RG, et al. P-selectin and leukocyte microparticles are associated with venous thrombogenesis. J Vasc Surg. 2003;38:1075–89.
    1. Closse C, Seigneur M, Renard M, Pruvost A, Dumain P, Belloc F, et al. Influence of hypoxia and hypoxia-reoxygenation on endothelial P-selectin expression. Thromb Res. 1997;85:159–64.
    1. Opal SM, Kessler CM, Roemisch J, Knaub S. Antithrombin, heparin, and heparan sulfate. Crit Care Med. 2002;30:S325–31.
    1. Ejiofor JA. Anticlotting mechanisms I: Physiology and pathology. Contin Educ Anesth Crit Care Pain. 2013;13:87–92.
    1. Price GC, Thompson SA, Kam PC. Tissue factor and tissue factor pathway inhibitor. Anaesthesia. 2004;59:483–92.
    1. Dahm AE, Sandset PM, Rosendaal FR. The association between protein S levels and anticoagulant activity of tissue factor pathway inhibitor type 1. J Thromb Haemost. 2008;6:393–5.
    1. Rigby AC, Grant MA. Protein S: A conduit between anticoagulation and inflammation. Crit Care Med. 2004;32:S336–41.
    1. Corral J, González-Conejero R, Hernández-Espinosa D, Vicente V. Protein Z/Z-dependent protease inhibitor (PZ/ZPI) anticoagulant system and thrombosis. Br J Haematol. 2007;137:99–108.
    1. Owens AP, 3rd, Mackman N. Tissue factor and thrombosis: The clot starts here. Thromb Haemost. 2010;104:432–9.
    1. Kumar V, Abbas AK, Fausto N, Aster JC. Robbins and Cotran Pathologic Basis of Disease. 8th ed. Philadelphia, PA: Saunders Elsevier; 2010. Hemodynamic disorders, thromboembolic disease and shock; pp. 118–20.
    1. Martlew VJ. Peri-operative management of patients with coagulation disorders. Br J Anaesth. 2000;85:446–55.
    1. Roberts HR, Stinchcombe TE, Gabriel DA. The dysfibrinogenaemias. Br J Haematol. 2001;114:249–57.
    1. Polderman HK. Hypothermia and coagulation. Crit Care. 2012;16:A20.
    1. Bauer KA. Pros and cons of new oral anticoagulants. Hematology Am Soc Hematol Educ Program 2013. 2013:464–70.
    1. Franchini M. Hemostasis and aging. Crit Rev Oncol Hematol. 2006;60:144–51.
    1. Coppola R, Mari D, Lattuada A, Franceschi C. Von Willebrand factor in Italian centenarians. Haematologica. 2003;88:39–43.
    1. Pinjala RK, Reddy LR, Nihar RP, Praveen GV, Sandeep M. Thrombophilia - How far and how much to investigate? Indian J Surg. 2012;74:157–62.
    1. Martinelli I, Bucciarelli P, Mannucci PM. Thrombotic risk factors: Basic pathophysiology. Crit Care Med. 2010;38:S3–9.
    1. Jagneaux T, Taylor DE, Kantrow SP. Coagulation in sepsis. Am J Med Sci. 2004;328:196–204.
    1. Cesarman-Maus G, Hajjar KA. Molecular mechanisms of fibrinolysis. Br J Haematol. 2005;129:307–21.
    1. Schuster V, Hügle B, Tefs K. Plasminogen deficiency. J Thromb Haemost. 2007;5:2315–22.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться